A new study pointed to three distinct factors that could be key indicators of stroke risk. The study also offers steps to ...
Opinion
Is ATLAS lifting the burden of stroke in people with large-vessel occlusion and low ASPECTS scores?
In Greek mythology, Atlas is the powerful Titan condemned by Zeus to eternally bear the celestial spheres—a profound symbol of endurance and strength. These very virtues are necessitated in patients ...
Hosted on MSN
Mastering the NIH stroke scale with confidence
The NIH Stroke Scale (NIHSS) is the gold standard for quickly and consistently assessing stroke severity. From emergency rooms to research trials, it guides treatment decisions, predicts outcomes, and ...
The Trump administration quietly conceded defeat last week on its misguided push to slash research funding from the National Institutes of Health. That’s a relief to researchers, but all Americans ...
A silhouette of a person looking through a microscope with a red computer screen in the background. Researchers looking for NIH funding in 2026 will likely find increased competition and ...
Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The last time Jay Bhattacharya testified before Congress, in early ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The newest rankings of research institutions based on National Institutes of Health funding ...
The risk of recurrent ischemic stroke can be reduced by managing modifiable risk factors and instituting a regimen of mechanism-specific secondary stroke prevention. Strategies for secondary ...
New stroke breakthroughs spotlight faster treatment, factor XI prevention, better recovery, and the push to deliver care equitably with smart wearables. The future of stroke care is likely to be ...
NEW ORLEANS -- Loberamisal improved functional outcomes after acute ischemic stroke in a placebo-controlled phase III trial, raising its prospects as an investigational neuroprotective therapy. In ...
NEW ORLEANS -- A stronger case could be made for intra-arterial (IA) alteplase after successful mechanical thrombectomy based on more randomized data, this time the CHOICE-2 trial from Spain. In acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results